ISSN: 2574-7800
Authors: Monica Trifitriana*
Psoriasis, a chronic inflammatory skin condition, poses significant challenges to patients and clinicians due to its unpredictable course and varied clinical manifestations. Conventional therapies often provide limited efficacy and are associated with adverse effects. However, the emergence of biologic agents has revolutionized psoriasis management by specifically targeting key inflammatory pathways, offering remarkable efficacy and safety profiles.
Keywords: Psoriasis
